Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The study is a multicenter trial conducted to compare the effectiveness of corticosteroid
control to mesenchymal stem cell preparations from autologous bone marrow concentrate (BMAC),
adipose derived stem cells in the form of Stromal Vascular Fraction (SVF), and third party
human mesenchymal stem cells manufactured from umbilical cord tissue (UCT) for the treatment
of unilateral Knee Osteoarthritis (OA). The study will be conducted in 4 sites in the United
States, including Emory University. A total of 480 participants will be enrolled in this
study.